Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
US11141468B2 · kind B2 · utility
1Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 2, 2017 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Jun 22, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y404/01011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is related to a new method for treating liquid and solid cancers, in a mammal, including human, wherein methioninase is administered before asparaginase. The invention also encompasses the use of a dietary methionine deprivation, possibly combined with methioninase administration, in advance of asparaginase treatment. Methioninase and asparaginase may be used in particular under free form, pegylated form or encapsulated into erythrocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.